Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
860,090
-
Shares change
-
+814,919
-
Total reported value, excl. options
-
$1,083,000
-
Value change
-
+$1,026,020
-
Number of buys
-
9
-
Price
-
$1.26
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q2 2016
12 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q2 2016.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 860,090 shares
of 113,177,462 outstanding shares and own 0.76% of the company stock.
Largest 10 shareholders include Sio Capital Management, LLC (554,382 shares), VANGUARD GROUP INC (205,575 shares), GEODE CAPITAL MANAGEMENT, LLC (31,264 shares), A.R.T. Advisors, LLC (20,300 shares), NORTHERN TRUST CORP (16,962 shares), CITADEL ADVISORS LLC (16,624 shares), WELLS FARGO & COMPANY/MN (6,250 shares), UBS Group AG (3,252 shares), Acrospire Investment Management LLC (2,300 shares), and MANUFACTURERS LIFE INSURANCE COMPANY, THE (1,807 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.